Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 64 entries
Sorted by: Best Match Show Resources per page
Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy.

Current treatment options in allergy

Kouser L, Kappen J, Walton RP, Shamji MH.
PMID: 28413769
Curr Treat Options Allergy. 2017;4(1):43-53. doi: 10.1007/s40521-017-0117-5. Epub 2017 Mar 10.

Allergen immunotherapy (AIT) is an immune modulating treatment for allergic diseases. Although highly effective, some patients do not respond to the treatment. To date there are no surrogate biomarkers that are predictive of the clinical response to AIT. More...

Cite
Kouser L, Kappen J, Walton RP, et al. Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy. Curr Treat Options Allergy. 2017;4(1):43-53doi: 10.1007/s40521-017-0117-5.
Kouser, L., Kappen, J., Walton, R. P., & Shamji, M. H. (2017). Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy. Current treatment options in allergy, 4(1), 43-53. https://doi.org/10.1007/s40521-017-0117-5
Kouser, Lubna, et al. "Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy." Current treatment options in allergy vol. 4,1 (2017): 43-53. doi: https://doi.org/10.1007/s40521-017-0117-5
Kouser L, Kappen J, Walton RP, Shamji MH. Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy. Curr Treat Options Allergy. 2017;4(1):43-53. doi: 10.1007/s40521-017-0117-5. Epub 2017 Mar 10. PMID: 28413769; PMCID: PMC5375961.
Copy Download .nbib Format: NLM
The Physiome Model Repository 2.

Bioinformatics (Oxford, England)

Yu T, Lloyd CM, Nickerson DP, Cooling MT, Miller AK, Garny A, Terkildsen JR, Lawson J, Britten RD, Hunter PJ, Nielsen PM.
PMID: 21216774
Bioinformatics. 2011 Mar 01;27(5):743-4. doi: 10.1093/bioinformatics/btq723. Epub 2011 Jan 06.

MOTIVATION: The Physiome Model Repository 2 (PMR2) software was created as part of the IUPS Physiome Project (Hunter and Borg, 2003), and today it serves as the foundation for the CellML model repository. Key advantages brought to the end...

Cite
Yu T, Lloyd CM, Nickerson DP, et al. The Physiome Model Repository 2. Bioinformatics. 2011;27(5):743-4doi: 10.1093/bioinformatics/btq723.
Yu, T., Lloyd, C. M., Nickerson, D. P., Cooling, M. T., Miller, A. K., Garny, A., Terkildsen, J. R., Lawson, J., Britten, R. D., Hunter, P. J., & Nielsen, P. M. (2011). The Physiome Model Repository 2. Bioinformatics (Oxford, England), 27(5), 743-4. https://doi.org/10.1093/bioinformatics/btq723
Yu, Tommy, et al. "The Physiome Model Repository 2." Bioinformatics (Oxford, England) vol. 27,5 (2011): 743-4. doi: https://doi.org/10.1093/bioinformatics/btq723
Yu T, Lloyd CM, Nickerson DP, Cooling MT, Miller AK, Garny A, Terkildsen JR, Lawson J, Britten RD, Hunter PJ, Nielsen PM. The Physiome Model Repository 2. Bioinformatics. 2011 Mar 01;27(5):743-4. doi: 10.1093/bioinformatics/btq723. Epub 2011 Jan 06. PMID: 21216774.
Copy Download .nbib Format: NLM
Retraction.

Thorax

[No authors listed]
PMID: 24083316
Thorax. 2013 Sep;68(9):886. doi: 10.1136/thoraxjnl-2011-200405ret.

No abstract available.

Cite
Retraction. Thorax. 2013;68(9):886doi: 10.1136/thoraxjnl-2011-200405ret.
(2013). Retraction. Thorax, 68(9), 886. https://doi.org/10.1136/thoraxjnl-2011-200405ret
"Retraction." Thorax vol. 68,9 (2013): 886. doi: https://doi.org/10.1136/thoraxjnl-2011-200405ret
Retraction. Thorax. 2013 Sep;68(9):886. doi: 10.1136/thoraxjnl-2011-200405ret. PMID: 24083316.
Copy Download .nbib Format: NLM
Viral infections and the development of asthma in children.

Therapeutic advances in infectious disease

Saglani S.
PMID: 25165549
Ther Adv Infect Dis. 2013 Aug;1(4):139-50. doi: 10.1177/2049936113497202.

Viral aetiology, host susceptibility (in particular allergic predisposition and sensitization), and illness severity, timing and frequency all appear to contribute as synergistic factors to the risk of developing asthma. Experimental models have shown both innate and adaptive immune responses...

Cite
Saglani S. Viral infections and the development of asthma in children. Ther Adv Infect Dis. 2013;1(4):139-50doi: 10.1177/2049936113497202.
Saglani, S. (2013). Viral infections and the development of asthma in children. Therapeutic advances in infectious disease, 1(4), 139-50. https://doi.org/10.1177/2049936113497202
Saglani, Sejal. "Viral infections and the development of asthma in children." Therapeutic advances in infectious disease vol. 1,4 (2013): 139-50. doi: https://doi.org/10.1177/2049936113497202
Saglani S. Viral infections and the development of asthma in children. Ther Adv Infect Dis. 2013 Aug;1(4):139-50. doi: 10.1177/2049936113497202. PMID: 25165549; PMCID: PMC4040725.
Copy Download .nbib Format: NLM
Reply.

The Journal of allergy and clinical immunology

Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H.
PMID: 27084400
J Allergy Clin Immunol. 2016 Jul;138(1):313-314. doi: 10.1016/j.jaci.2016.01.042. Epub 2016 Apr 12.

No abstract available.

Cite
Bønnelykke K, Vissing NH, Sevelsted A, et al. Reply. J Allergy Clin Immunol. 2016;138(1):313-314doi: 10.1016/j.jaci.2016.01.042.
Bønnelykke, K., Vissing, N. H., Sevelsted, A., Johnston, S. L., & Bisgaard, H. (2016). Reply. The Journal of allergy and clinical immunology, 138(1), 313-314. https://doi.org/10.1016/j.jaci.2016.01.042
Bønnelykke, Klaus, et al. "Reply." The Journal of allergy and clinical immunology vol. 138,1 (2016): 313-314. doi: https://doi.org/10.1016/j.jaci.2016.01.042
Bønnelykke K, Vissing NH, Sevelsted A, Johnston SL, Bisgaard H. Reply. J Allergy Clin Immunol. 2016 Jul;138(1):313-314. doi: 10.1016/j.jaci.2016.01.042. Epub 2016 Apr 12. PMID: 27084400.
Copy Download .nbib Format: NLM
National clinical practice guidelines for food allergy and anaphylaxis: an international assessment.

Clinical and translational allergy

Sheikh A, Sheikh Z, Roberts G, Muraro A, Dhami S, Sheikh A.
PMID: 28770042
Clin Transl Allergy. 2017 Jul 25;7:23. doi: 10.1186/s13601-017-0161-z. eCollection 2017.

BACKGROUND: Clinical practice guidelines are important tools to promote evidence-based clinical care, but not all countries have the capacity or infrastructure to develop these in-house. The European Academy of Allergy and Clinical Immunology has recently developed guidelines for the...

Cite
Sheikh A, Sheikh Z, Roberts G, et al. National clinical practice guidelines for food allergy and anaphylaxis: an international assessment. Clin Transl Allergy. 2017;7:23doi: 10.1186/s13601-017-0161-z.
Sheikh, A., Sheikh, Z., Roberts, G., Muraro, A., Dhami, S., & Sheikh, A. (2017). National clinical practice guidelines for food allergy and anaphylaxis: an international assessment. Clinical and translational allergy, 723. https://doi.org/10.1186/s13601-017-0161-z
Sheikh, Asiyah, et al. "National clinical practice guidelines for food allergy and anaphylaxis: an international assessment." Clinical and translational allergy vol. 7 (2017): 23. doi: https://doi.org/10.1186/s13601-017-0161-z
Sheikh A, Sheikh Z, Roberts G, Muraro A, Dhami S, Sheikh A. National clinical practice guidelines for food allergy and anaphylaxis: an international assessment. Clin Transl Allergy. 2017 Jul 25;7:23. doi: 10.1186/s13601-017-0161-z. eCollection 2017. PMID: 28770042; PMCID: PMC5525365.
Copy Download .nbib Format: NLM
Common features of tuberculosis and sarcoidosis.

International journal of mycobacteriology

Mortaz E, Masjedi MR, Abedini A, Matroodi S, Kiani A, Soroush D, Adcock IM.
PMID: 28043581
Int J Mycobacteriol. 2016 Dec;5:S240-S241. doi: 10.1016/j.ijmyco.2016.09.031. Epub 2016 Nov 09.

Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis. Despite the availability of novel therapeutic approaches, TB is considered as one of the leading causes of death due to infectious diseases worldwide. Alveolar macrophages are the first line of...

Cite
Mortaz E, Masjedi MR, Abedini A, et al. Common features of tuberculosis and sarcoidosis. Int J Mycobacteriol. 2016;5:S240-S241doi: 10.1016/j.ijmyco.2016.09.031.
Mortaz, E., Masjedi, M. R., Abedini, A., Matroodi, S., Kiani, A., Soroush, D., & Adcock, I. M. (2016). Common features of tuberculosis and sarcoidosis. International journal of mycobacteriology, 5S240-S241. https://doi.org/10.1016/j.ijmyco.2016.09.031
Mortaz, Esmaeil, et al. "Common features of tuberculosis and sarcoidosis." International journal of mycobacteriology vol. 5 (2016): S240-S241. doi: https://doi.org/10.1016/j.ijmyco.2016.09.031
Mortaz E, Masjedi MR, Abedini A, Matroodi S, Kiani A, Soroush D, Adcock IM. Common features of tuberculosis and sarcoidosis. Int J Mycobacteriol. 2016 Dec;5:S240-S241. doi: 10.1016/j.ijmyco.2016.09.031. Epub 2016 Nov 09. PMID: 28043581.
Copy Download .nbib Format: NLM
The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing.

International journal of mycobacteriology

Mortaz E, Alipoor SD, Tabarsi P, Adcock IM, Garssen J, Velayati AA.
PMID: 28043542
Int J Mycobacteriol. 2016 Dec;5:S184-S185. doi: 10.1016/j.ijmyco.2016.09.045. Epub 2016 Nov 11.

OBJECTIVE/BACKGROUND: Tuberculosis (TB) is a major global threat to human health, especially in low-income countries. The diagnosis of TB is challenging because of the limitations of specificity and sensitivity with the current diagnostics. Novel, selective biomarkers for TB would...

Cite
Mortaz E, Alipoor SD, Tabarsi P, et al. The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing. Int J Mycobacteriol. 2016;5:S184-S185doi: 10.1016/j.ijmyco.2016.09.045.
Mortaz, E., Alipoor, S. D., Tabarsi, P., Adcock, I. M., Garssen, J., & Velayati, A. A. (2016). The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing. International journal of mycobacteriology, 5S184-S185. https://doi.org/10.1016/j.ijmyco.2016.09.045
Mortaz, Esmaeil, et al. "The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing." International journal of mycobacteriology vol. 5 (2016): S184-S185. doi: https://doi.org/10.1016/j.ijmyco.2016.09.045
Mortaz E, Alipoor SD, Tabarsi P, Adcock IM, Garssen J, Velayati AA. The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing. Int J Mycobacteriol. 2016 Dec;5:S184-S185. doi: 10.1016/j.ijmyco.2016.09.045. Epub 2016 Nov 11. PMID: 28043542.
Copy Download .nbib Format: NLM
Corrigendum to "Determinants of pulmonary dead space in ventilated newborn infants" [Early Hum. Dev. 108 (2017) 29-32].

Early human development

Dassios T, Kaltsogianni O, Greenough A.
PMID: 28602431
Early Hum Dev. 2017 Aug;111:60. doi: 10.1016/j.earlhumdev.2017.06.001. Epub 2017 Jun 08.

No abstract available.

Cite
Dassios T, Kaltsogianni O, Greenough A. Corrigendum to "Determinants of pulmonary dead space in ventilated newborn infants" [Early Hum. Dev. 108 (2017) 29-32]. Early Hum Dev. 2017;111:60doi: 10.1016/j.earlhumdev.2017.06.001.
Dassios, T., Kaltsogianni, O., & Greenough, A. (2017). Corrigendum to "Determinants of pulmonary dead space in ventilated newborn infants" [Early Hum. Dev. 108 (2017) 29-32]. Early human development, 11160. https://doi.org/10.1016/j.earlhumdev.2017.06.001
Dassios, Theodore, et al. "Corrigendum to "Determinants of pulmonary dead space in ventilated newborn infants" [Early Hum. Dev. 108 (2017) 29-32]." Early human development vol. 111 (2017): 60. doi: https://doi.org/10.1016/j.earlhumdev.2017.06.001
Dassios T, Kaltsogianni O, Greenough A. Corrigendum to "Determinants of pulmonary dead space in ventilated newborn infants" [Early Hum. Dev. 108 (2017) 29-32]. Early Hum Dev. 2017 Aug;111:60. doi: 10.1016/j.earlhumdev.2017.06.001. Epub 2017 Jun 08. PMID: 28602431.
Copy Download .nbib Format: NLM
Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection.

Nature communications

Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EH, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C.
PMID: 26957359
Nat Commun. 2016 Mar 09;7:11011. doi: 10.1038/ncomms11011.

No abstract available.

Cite
Jozwik A, Habibi MS, Paras A, et al. Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun. 2016;7:11011doi: 10.1038/ncomms11011.
Jozwik, A., Habibi, M. S., Paras, A., Zhu, J., Guvenel, A., Dhariwal, J., Almond, M., Wong, E. H., Sykes, A., Maybeno, M., Del Rosario, J., Trujillo-Torralbo, M. B., Mallia, P., Sidney, J., Peters, B., Kon, O. M., Sette, A., Johnston, S. L., Openshaw, P. J., & Chiu, C. (2016). Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nature communications, 711011. https://doi.org/10.1038/ncomms11011
Jozwik, Agnieszka, et al. "Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection." Nature communications vol. 7 (2016): 11011. doi: https://doi.org/10.1038/ncomms11011
Jozwik A, Habibi MS, Paras A, Zhu J, Guvenel A, Dhariwal J, Almond M, Wong EH, Sykes A, Maybeno M, Del Rosario J, Trujillo-Torralbo MB, Mallia P, Sidney J, Peters B, Kon OM, Sette A, Johnston SL, Openshaw PJ, Chiu C. Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection. Nat Commun. 2016 Mar 09;7:11011. doi: 10.1038/ncomms11011. PMID: 26957359; PMCID: PMC4786878.
Copy Download .nbib Format: NLM
Idiopathic Anaphylaxis.

Current treatment options in allergy

Nwaru BI, Dhami S, Sheikh A.
PMID: 28890861
Curr Treat Options Allergy. 2017;4(3):312-319. doi: 10.1007/s40521-017-0136-2. Epub 2017 Jun 03.

Idiopathic anaphylaxis is a rare life-threatening disorder with symptoms similar to other forms of anaphylaxis. There is lack of a robust evidence base underpinning the treatment of anaphylaxis and even less so for idiopathic anaphylaxis. Much of the evidence...

Cite
Nwaru BI, Dhami S, Sheikh A. Idiopathic Anaphylaxis. Curr Treat Options Allergy. 2017;4(3):312-319doi: 10.1007/s40521-017-0136-2.
Nwaru, B. I., Dhami, S., & Sheikh, A. (2017). Idiopathic Anaphylaxis. Current treatment options in allergy, 4(3), 312-319. https://doi.org/10.1007/s40521-017-0136-2
Nwaru, Bright I, et al. "Idiopathic Anaphylaxis." Current treatment options in allergy vol. 4,3 (2017): 312-319. doi: https://doi.org/10.1007/s40521-017-0136-2
Nwaru BI, Dhami S, Sheikh A. Idiopathic Anaphylaxis. Curr Treat Options Allergy. 2017;4(3):312-319. doi: 10.1007/s40521-017-0136-2. Epub 2017 Jun 03. PMID: 28890861; PMCID: PMC5569651.
Copy Download .nbib Format: NLM
Formula one: best is no formula.

The European respiratory journal

Bush A, Custovic A.
PMID: 28461302
Eur Respir J. 2017 May 01;49(5). doi: 10.1183/13993003.00105-2017. Print 2017 May.

No abstract available.

Cite
Bush A, Custovic A. Formula one: best is no formula. Eur Respir J. 2017;49(5)doi: 10.1183/13993003.00105-2017.
Bush, A., & Custovic, A. (2017). Formula one: best is no formula. The European respiratory journal, 49(5), . https://doi.org/10.1183/13993003.00105-2017
Bush, Andrew, and Custovic, Adnan. "Formula one: best is no formula." The European respiratory journal vol. 49,5 (2017). doi: https://doi.org/10.1183/13993003.00105-2017
Bush A, Custovic A. Formula one: best is no formula. Eur Respir J. 2017 May 01;49(5). doi: 10.1183/13993003.00105-2017. Print 2017 May. PMID: 28461302.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 64 entries